Prieto-Alhambra, D <br/><br/>
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Jan 2014 
 - 77-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-013-2420-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--therapeutic use<br/>Cognition Disorders--complications<br/>Diphosphonates--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Hip Fractures--epidemiology<br/>Humans<br/>Imidazoles--therapeutic use<br/>Incidence<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Osteoporosis--complications<br/>Osteoporotic Fractures--epidemiology<br/>Psychiatric Status Rating Scales<br/>Secondary Prevention<br/>Treatment Outcome<br/>Zoledronic Acid